Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with 'untargeted' side effects.

Berends, Annika M A; van der Horst-Schrivers, Anouk N A; Oosting, Sjoukje F; Kapiteijn, Ellen W; de Groot, Jan Willem B; Links, Thera P

Berends, Annika M A; van der Horst-Schrivers, Anouk N A; Oosting, Sjoukje F; Kapiteijn, Ellen W; de Groot, Jan Willem B; Links, Thera P.

Affiliation

Berends AMA; Department of Endocrinology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
van der Horst-Schrivers ANA; Department of Endocrinology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Oosting SF; Department of Medical Oncology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Kapiteijn EW; Department of Medical Oncology, Division of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
de Groot JWB; Isala Oncology Center, Zwolle, The Netherlands.
Links TP; Department of Endocrinology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.

Acta Oncol ; 59(6): 726-729, 2020 Jun.

Article de En | MEDLINE | ID: mdl-32056474

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phénylurées / Quinoléines / Tumeurs de la thyroïde / Calcium / Adénocarcinome folliculaire / Inhibiteurs de protéines kinases / Hypocalcémie Limites: Aged / Female / Humans Langue: En Journal: Acta Oncol Sujet du journal: NEOPLASIAS Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google